Cargando…

Understanding Biomarkers in Early-Stage Invasive Breast Cancer: Tools From the ASCO Clinical Guideline

Detalles Bibliográficos
Autor principal:	Mayden, Kelley D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866132/ https://www.ncbi.nlm.nih.gov/pubmed/29588871

Ejemplares similares

Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Costas-Chavarri, Ainhoa, et al.
Publicado: (2019)

Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Lopes, Gilberto, et al.
Publicado: (2019)

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Chiorean, E. Gabriela, et al.
Publicado: (2020)

ASCO 2016: highlights in breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2016)

ASCO 2017: highlights in breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2017)

ASCO 2020: highlights in breast cancer
por: Bartsch, Rupert
Publicado: (2021)

ASCO Resource-Stratified Guidelines: Methods and Opportunities
por: Al-Sukhun, Sana, et al.
Publicado: (2018)

Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline
por: Jeronimo, Jose, et al.
Publicado: (2016)

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update
por: Chuang, Linus T., et al.
Publicado: (2022)

Highlights in breast cancer from ASCO 2016
por: Cardoso, Fatima
Publicado: (2016)

ASCO 2018 highlights: metastatic breast cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018)

Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update
por: Shastri, Surendra S., et al.
Publicado: (2022)

Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
por: Wang, Bo, et al.
Publicado: (2019)

Chemotherapy Treatment Considerations in Metastatic Breast Cancer
por: Hanna, Kirollos, et al.
Publicado: (2021)

Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines
por: Nagarjun, B. R., et al.
Publicado: (2022)

Breast and gastrointestinal cancer updates from ASCO 2015
por: Dawood, Shaheenah
Publicado: (2015)

The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner
por: Hanna, Kirollos, et al.
Publicado: (2021)

The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer
por: Hanna, Kirollos, et al.
Publicado: (2021)

Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience
por: Varga, Zsuzsanna, et al.
Publicado: (2015)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline
por: Osman, Hibah, et al.
Publicado: (2018)

SEOM clinical guidelines in early-stage breast cancer 2015
por: Garcia-Saenz, J. A., et al.
Publicado: (2015)

SEOM clinical guidelines in early stage breast cancer (2018)
por: Ayala de la Peña, F., et al.
Publicado: (2018)

ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)

From ASCO 2022
por: Romero, Diana
Publicado: (2022)

Highlights of ASCO 2023
por: Neugut, Alfred I, et al.
Publicado: (2023)

Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
por: Abraham, Jame, et al.
Publicado: (2020)

ASCO 2017—highlights of gynecological cancer
por: Radl, Bianca, et al.
Publicado: (2017)

Neues aus der Urologie von GU-ASCO, ASCO und EAU
por: Schnabel, Marco J., et al.
Publicado: (2020)

Hodentumoren: neue Erkenntnisse von ASCO-GU, ASCO und EAU 2021
por: Schrader, Mark
Publicado: (2021)

Novel therapies in breast cancer: what is new from ASCO 2008
por: Chu, David, et al.
Publicado: (2008)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer
Publicado: (2019)

Breast Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Breast Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2022)

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
por: Press, Michael F., et al.
Publicado: (2018)

Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline
por: Vanderpuye, Verna D., et al.
Publicado: (2021)

SIO-ASCO guideline on integrative medicine for cancer pain management: implications for racial and ethnic pain disparities
por: Liou, Kevin T, et al.
Publicado: (2023)

Breast Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_psg6idc7ims8526rt4m3t50dab